Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, four-period, two-treatment, two-sequence, balanced, single
dose, crossover, oral bioequivalence study in healthy, adult, human subjects under fasting
conditions.